116 related articles for article (PubMed ID: 38629299)
1. The impact of SOX4-activated CTHRC1 transcriptional activity regulating DNA damage repair on cisplatin resistance in lung adenocarcinoma.
Ai C; Huang Z; Rong T; Shen W; Yang F; Li Q; Bi L; Li W
Electrophoresis; 2024 Apr; ():. PubMed ID: 38629299
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL3.
Wang T; Zhu X; Wang K; Li J; Hu X; Lin P; Zhang J
Pulm Pharmacol Ther; 2023 Jun; 80():102217. PubMed ID: 37121465
[TBL] [Abstract][Full Text] [Related]
3. SNHG15 enhances cisplatin resistance in lung adenocarcinoma by affecting the DNA repair capacity of cancer cells.
Li Y; Huang HQ; Huang ZH; Yu ND; Ye XL; Jiang MC; Chen LM
Diagn Pathol; 2023 Mar; 18(1):33. PubMed ID: 36864456
[TBL] [Abstract][Full Text] [Related]
4. Activation of CTHRC1 by HOXB9 Promotes Angiogenesis through Fatty Acid Metabolism in Lung Adenocarcinoma.
Liu K; Li X; Yang Z; Zhang R
Rev Invest Clin; 2022; 75(2):63-75. PubMed ID: 37205792
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor E2F8 activates PDK1-mediated DNA damage repair to enhance cisplatin resistance in lung adenocarcinoma.
Li H; Sun J; Hu H; Wang Y
Pharmacology; 2024 May; ():. PubMed ID: 38810606
[TBL] [Abstract][Full Text] [Related]
6. WDHD1 Leads to Cisplatin Resistance by Promoting MAPRE2 Ubiquitination in Lung Adenocarcinoma.
Gong L; Xiao M; He D; Hu Y; Zhu Y; Xiang L; Bao Y; Liu X; Zeng Q; Liu J; Zhou M; Zhou Y; Cheng Y; Zhang Y; Deng L; Zhu R; Lan H; Cao K
Front Oncol; 2020; 10():461. PubMed ID: 32426268
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circ-RNF121 contributes to cisplatin (DDP) resistance of non-small-cell lung cancer cells by regulating the miR-646/SOX4 axis.
Liu Y; Zhai R; Hu S; Liu J
Anticancer Drugs; 2022 Jan; 33(1):e186-e197. PubMed ID: 34387608
[TBL] [Abstract][Full Text] [Related]
8. TFAP2A Upregulates SKA3 to Promote Glycolysis and Reduce the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin.
Liu G; Liu X; Zeng W; Zhou W
Pharmacology; 2024 Apr; ():1-14. PubMed ID: 38643755
[TBL] [Abstract][Full Text] [Related]
9. CTHRC1 targeted by miR-30a-5p regulates cell adhesion, invasion and migration in lung adenocarcinoma.
Yang C; Huang T; Liang Y; Xue Y; Liang Y; Wei X; Meng F; Wei Q
J Cardiothorac Surg; 2022 Mar; 17(1):46. PubMed ID: 35313900
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
[TBL] [Abstract][Full Text] [Related]
11. LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway.
Shi W; Ling L; Li C; Wu R; Zhang M; Shao F; Wang Y
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1295-1311. PubMed ID: 35792913
[TBL] [Abstract][Full Text] [Related]
12.
Wang Z; Zhou L; Chen B; Li X; Zou Q; Xu W; Fang L; Wu A; Li Z; Chen Y
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107669
[TBL] [Abstract][Full Text] [Related]
13. [Role of SOX4 on DDP Resistance in Non-small Cell Lung Cancer Cell of A549].
Li W; Liu X; Zhang G; Zhang L
Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):298-302. PubMed ID: 28532536
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4.
Hu B; Zhang H; Wang Z; Zhang F; Wei H; Li L
Cancer Biol Ther; 2017 Dec; 18(12):974-983. PubMed ID: 29020498
[TBL] [Abstract][Full Text] [Related]
15. Let-7c-5p Represses Cisplatin Resistance of Lung Adenocarcinoma Cells by Targeting CDC25A.
Huang L; Lou K; Wang K; Liang L; Chen Y; Zhang J
Appl Biochem Biotechnol; 2023 Mar; 195(3):1644-1655. PubMed ID: 36355336
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-133a-3p Inhibits Lung Adenocarcinoma Development and Cisplatin Resistance through Targeting GINS4.
Zhou Y; Yan J; Chen H; Zhou W; Yang J
Cells Tissues Organs; 2024; 213(1):55-66. PubMed ID: 36273455
[TBL] [Abstract][Full Text] [Related]
17. Hsa-miR-503-5p regulates CTDSPL to accelerate cisplatin resistance and angiogenesis of lung adenocarcinoma cells.
Han J; Wang Y
Chem Biol Drug Des; 2023 Oct; 102(4):749-762. PubMed ID: 37341065
[TBL] [Abstract][Full Text] [Related]
18. Circ-SOX4 drives the tumorigenesis and development of lung adenocarcinoma via sponging miR-1270 and modulating PLAGL2 to activate WNT signaling pathway.
Gao N; Ye B
Cancer Cell Int; 2020; 20():2. PubMed ID: 31911754
[TBL] [Abstract][Full Text] [Related]
19. LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells by Targeting the miR-200a/β-Catenin Pathway.
Tang W; Yu X; Zeng R; Chen L
Cancer Manag Res; 2020; 12():2001-2014. PubMed ID: 32256108
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation.
Gong L; Hu Y; He D; Zhu Y; Xiang L; Xiao M; Bao Y; Liu X; Zeng Q; Liu J; Zhou M; Zhou Y; Cheng Y; Zhang Y; Deng L; Zhu R; Lan H; Cao K
Cancer Cell Int; 2020; 20():194. PubMed ID: 32508530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
